Home › IGA Glomerulonephritis › Colorado
IGA Glomerulonephritis clinical trials in Colorado
7 studies for IGA Glomerulonephritis are looking for participants at sites in Colorado.
Cities in Colorado
A Study of JADE101 in Participants With Immunoglobulin A Nephropathy
- Jade Clinical Site, Arvada
- Jade Clinical Site, Denver
RecruitingPhase 2
Ages 18 to 60 · All sexes · Updated Sep 25, 2026 · NCT07541287Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Iptacopan in Pediatric Patients With Primary IgAN
- Childrens Hospital Colorado, Aurora
RecruitingPhase 3
Ages 2 to 18 · All sexes · Updated Sep 9, 2026 · NCT06994845Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
- Colorado Kidney Care Nephrology, Denver
RecruitingPhase 3
Ages 18 to 100 · All sexes · Updated Aug 17, 2026 · NCT06858319A Study to Assess the Effects of Zigakibart on IgA Nephropathy.
- Colorado Kidney Care Nephrology, Denver
RecruitingPhase 2
Ages 18 to 100 · All sexes · Updated Aug 10, 2026 · NCT07146906Study of WAL0921 in Patients With Glomerular Kidney Diseases
- Colorado Kidney and Vascular Care, Denver
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Aug 3, 2026 · NCT06466135Study of Ravulizumab in Pediatric Participants With Primary IgAN
- Research Site, Aurora
RecruitingPhase 3
Ages 2 to 18 · All sexes · Updated Jul 30, 2026 · NCT07024563Trial of the Impact of Sibeprenlimab on Immunoglobulin A Nephropathy Kidney Tissue
- Clinical Research Site 330, Denver
RecruitingPhase 2
Ages 16 and older · All sexes · Updated Apr 6, 2025 · NCT06740526From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.